Alendronate sodium
This is licensed for the prevention and treatment of postmenopausal osteoporosis.
It is also licensed for the prevention and treatment of steroid induced osteoporosis.
The summary of Product Characteristics must be consulted before prescribing this drug.
Related pages
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page